Evaluation of a covered-rod silicone implant containing ivermectin fo r long-term prevention of heartworm infection in dogs

American Journal of Veterinary Research

Volumn 67, Issue 9, 2006, Pages 1564-1569

  Cunningham, Craig P ^a   Brown, Jenaay M ^a   Jacobson, Glenn A ^b   Brandon, Malcolm R ^a   Martinod, Serge R ^a  

^a Smart Drug System Inc   (United States)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; PARASITE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIROFILARIA IMMITIS; DOG; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; EXPERIMENTAL INFECTION; FEMALE; FILARIASIS; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LARVAL STAGE; MALE; NONHUMAN; PREVENTIVE MEDICINE; SILICONE PROSTHESIS;

ANIMALS; ANTHELMINTICS; ANTIGENS, HELMINTH; DIROFILARIA IMMITIS; DIROFILARIASIS; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; FEMALE; HEART; IVERMECTIN; LUNG; MALE; SILICONES;

ANIMALIA; CANIS FAMILIARIS; DIROFILARIA IMMITIS;

EID: 33748743976     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.67.9.1564     Document Type: Article

References (19)

1. Blair LS, Campbell WC. Efficacy of ivermectin against Dirofilaria immitis larvae in dogs 31, 60 and 90 days after infection. Am J Vet Res 1980;41:2108.
2. McCall JW. The safety-net story about macrocyclic lactone heartworm preventives: a review, an update and recommendations. Vet Parasitol 2005;133:197-206.
3. McCall JW, Dzimianski MT, Plue RE, et al. Ivermectin in heartworm prophylaxis: study with experimentally induced and naturally acquired infections. In: Otto GF, ed. Proceedings of the Heartworm Symposium '86. Washington, DC: American Heartworm Society, 1986;9-13.
4. Grieve RB, Frank GR, Stewart VA, et al. Chemoprophylactic effects of milbemycin oxime against larvae of Dirofilaria immitis during prepatent development. Am J Vet Res 1991;52:2040-2042.
5. McCall JW, McTier TL, Holmes RA, et al. Prevention of naturally acquired heartworm infection in heartworm-naïve beagles by oral administration of moxidectin at an interval of either one or two months. In: Soll MD, ed. Proceedings of the Heartworm Symposium '92. Batavia, III: American Heartworm Society, 1992:169-177.
6. McTier TL, McCall JW, Jernigan AD, et al. UK-124,114, a novel avermectin for the prevention of heartworms in dogs and cats. In: Seward RL, Knight DH, eds. Proceedings of the Heartworm Symposium '98. Batavia, III: American Heartworm Society, 1998;187-192.
7. Genchi C, Poglayen G, Kramer LH, et al. Efficacy of moxidectin for the prevention of adult heartworm (Dirofilaria immitis) infection in dogs. Parassitologia 2001;43:139-141.
8. Heaney K, Lindahl RG. Safety evaluation of moxidectin sustained-release injectable in 10-week-old puppies. Vet Parasitol 2005;133:227-231.
9. Clark SL, Crowley AJ, Schmidt PG, et al. Long-term delivery of ivermectin by use of poly(D,L-lactic-co-glycolic) acid microparticles in dogs. Am J Vet Res 2004;65:752-757.
10. Maeda H, Brandon M, Sano A. Design of controlled-release formulation for ivermectin using silicone. Int J Pharm 2003;261:9-19.
11. Kajihara M, Sugie T, Hojo T, et al. Development of a new drug delivery system for protein drugs using silicone (II). J Control Release 2001;73:279-291.
12. Bourget P, Delouis JM. Review of a technique for the estimation of area under the concentration curve in pharmacokinetic analysis. Therapie 1993;48:1-5.
13. Daurio CP Cheung En, Jeffcoat AR, et al. Bioavailability of ivermectin administered orally to dogs. Vet Res Comm 1992;16:125-130.
14. Lok JB, Knight DH, Wang GT, et al. Activity of an injectable, sustained-release formulation of moxidectin administered prophylactically to mixed-breed dogs to prevent infection with Dirofilaria immitis. Am J Vet Res 2001;62:1721-1726.
15. McCall JW, Lindemann BA, Porter CA. Prophylactic activity of avermectins against experimentally induced Dirofilaria immitis infection in dogs. In: Otto GF, ed. Proceedings of the Heartworm Symposium '80. Edwardsville, Kan: Veterinary Medicine Publishing Co, 1981;126-130.
16. Nelson CT, McCall JW Rubin SB, et al. 2005 guidelines for the diagnosis, prevention and management of heartworm (Dirofilaria immitis) infection in dogs. Vet Parasitol 2005;133:255-266.
17. Cummings J, Vickers L, Marbaugh J. Evaluation of veterinary dispensing records to measure "clinic compliance" with recommended heartworm prevention programs. In: Soll MD, Knight DH, eds. Proceedings of the Heartworm Symposium '95. Batavia, III: American Heartworm Society, 1995;183-186.
18. Pulliam JD, Seward RL, Henry RT, et al. Investigating ivermectin toxicity in Collies. Vet Med 1985;80:33-40.
19. Mealy KL, Bentjen SA, Gay JM, et al. Ivermectin sensitivity in Collies is associated with a deletion mutation of the MDR1 gene. Pharmacogenetics 2001;11:727-733.